[Treatment of visceral leishmaniasis with liposomal amphotericin B in three immunocompromised patients].
Rodríguez-Wilhelmi
P
P
Panizo
C
C
Ruza
E
E
Rocha
E
E
D000368:Aged; D000666:Amphotericin B / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D002675:Child, Preschool; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007898:Leishmaniasis, Visceral / Q000188:drug therapy*; D008297:Male; D009894:Opportunistic Infections / Q000188:drug therapy*
D000981:Antiprotozoal Agents; D000666:Amphotericin B